Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2
2026-03-12
← Back to Journals
Blood and Lymphatic Cancer-Targets and Therapy
- Publisher:
- —
- ISSN:
- 1179-9889
- Category:
- ONCOLOGY
- Impact factor:
- 3.9
Feed status
8 parsed articles
Last update: Not fetched
Latest articles
Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
2025-12-06
The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
2025-09-24
Comprehensive Evaluation of Drug-Related Problems and Pharmacotherapy Patterns in Non-Hodgkin’s Lymphoma Patients in Yemen
2025-09-03
Neutrophil-Related Genes Predict Prognosis and Contribute to Immunosuppression in Acute Myeloid Leukemia
2025-08-18
Clinical Characteristics, Prognostic Risk Factors, and Primary Treatment for Elderly Patients with Primary Central Nervous System Lymphoma: A Seer Database-Based Research
2025-07-07
T-Cell Engagers In Multiple Myeloma: A Clinical Review
2025-03-24
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF
2024-07-29